We serve 7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one CAS:120004-79-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one
CAS.NO: 120004-79-7
Synonyms:
7-(4-chlorobutoxy)-3,4-dihydro-1H-quinolin-2-one
Molecular Formula: C13H16ClNO2
Molecular Weight:253.72500
Physical and Chemical Properties:
Density: 1.187 g/cm3
Boiling point: 448.925ºC at 760 mmHg
Melting point: /
Flash point: 225.302ºC
Refractive index: 1.543
Specification:
Appearance:White to off-white crystalline powder
Purity:≥98%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Aripiprazole CAS:129722-12-9
Contact us for information like 7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-(4-chlorobutoxy)-3,4-dihydro-1H-quinolin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-(4-chlorobutoxy)-3,4-dihydro-1H-quinolin-2-one Use and application,7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one technical grade,usp/ep/jp grade.
Related News: At a national conference on TCM last October, Xi urged experts and officials to carry on and innovate the fine elements in TCM and underlined efforts to promote it internationally, Xinhua reported at the time.6-bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7-one manufacturer The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.Cyclopentyl methyl ether supplier The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.2-methylsulfanylpyrazine vendor The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.
